— Know what they know.
Not Investment Advice

300357.SZ SHZ

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
1W: +0.7% 1M: -9.1% 3M: -14.9% YTD: -26.9% 1Y: -22.1% 3Y: -40.1% 5Y: -65.3%
¥20.33 ($3.03)
+0.51 (+2.57%)
 
SHZ · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · ¥10.6B mcap · 263M float · 4.21% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 78 Grade A+
Profitability
87
Balance Sheet
92
Earnings Quality
68
Growth
63
Value
55
Momentum
81
Safety
100
Cash Flow
90
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. 300357.SZ scores highest in Safety (100/100) and lowest in Value (55/100). An overall grade of A+ places 300357.SZ among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
32.99
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✗ ✗ ✗ ✓ ✗ ✓
Beneish M-Score
-1.93
Unlikely Manipulator
Ohlson O-Score
-14.06
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 95.0/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.00x
Accruals: 0.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. 300357.SZ scores 32.99, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. 300357.SZ scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. 300357.SZ's score of -1.93 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. 300357.SZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. 300357.SZ receives an estimated rating of AAA (score: 95.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). 300357.SZ's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
25.45x
PEG
1.20x
P/S
9.74x
P/B
3.86x
P/FCF
33.96x
P/OCF
29.18x
EV/EBITDA
21.33x
EV/Revenue
9.79x
EV/EBIT
22.73x
EV/FCF
29.94x
Earnings Yield
3.44%
FCF Yield
2.94%
Shareholder Yield
0.43%
Graham Number
$9.71
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 25.4x earnings, 300357.SZ commands a growth premium. Graham's intrinsic value formula yields $9.71 per share, 109% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.881
NI / EBT
×
Interest Burden
1.006
EBT / EBIT
×
EBIT Margin
0.431
EBIT / Rev
×
Asset Turnover
0.372
Rev / Assets
×
Equity Multiplier
1.125
Assets / Equity
=
ROE
16.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. 300357.SZ's ROE of 16.0% is driven by EBIT Margin (0.431) as the dominant factor.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
9.68%
Fair P/E
27.87x
Intrinsic Value
$22.22
Price/Value
1.04x
Margin of Safety
-4.29%
Premium
4.29%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with 300357.SZ's realized 9.7% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. 300357.SZ trades at a 4% premium to its adjusted intrinsic value of $22.22, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 27.9x compares to the current market P/E of 25.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$20.33
Median 1Y
$17.76
5th Pctile
$8.63
95th Pctile
$36.56
Ann. Volatility
43.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 21.1% 21.2% 21.4% 22.3% 21.6% 18.8% 16.9% 16.5% 14.2% 14.9% 14.7% 14.6% 13.9% 14.0% 13.4% 14.7% 15.6% 15.3% 16.5% 16.0% 15.98%
ROA 19.0% 19.1% 19.6% 20.4% 19.5% 16.9% 15.5% 14.3% 12.5% 13.0% 13.0% 12.1% 12.0% 12.1% 11.9% 12.6% 14.0% 13.6% 15.2% 14.2% 14.22%
ROIC 42.9% 45.1% 44.2% 47.4% 42.3% 38.8% 33.4% 37.7% 27.6% 31.0% 28.5% 30.0% 26.0% 29.0% 26.6% 29.9% 28.4% 28.6% 26.8% 28.2% 28.19%
ROCE 19.4% 19.0% 19.3% 20.3% 19.7% 18.2% 16.3% 15.1% 13.1% 12.9% 13.0% 13.1% 12.4% 13.0% 12.5% 13.5% 15.1% 15.1% 16.4% 16.3% 16.32%
Gross Margin 96.2% 95.2% 95.9% 95.6% 95.5% 93.9% 94.7% 95.1% 96.0% 94.7% 95.2% 94.7% 95.7% 94.8% 94.8% 95.4% 95.7% 94.7% 95.2% 90.0% 90.03%
Operating Margin 55.6% 39.3% 53.1% 53.4% 54.4% 10.1% 40.7% 41.9% 49.0% 25.5% 40.7% 39.6% 47.8% 27.1% 37.1% 45.6% 50.6% 19.5% 40.1% 40.1% 40.11%
Net Margin 46.8% 33.7% 46.4% 46.7% 46.9% 11.0% 38.5% 38.5% 42.3% 23.0% 35.7% 33.8% 40.9% 23.3% 32.5% 40.1% 45.5% 17.3% 47.2% 36.1% 36.05%
EBITDA Margin 54.3% 28.9% 51.6% 51.9% 53.7% 17.3% 39.1% 41.1% 48.5% 21.0% 40.8% 40.6% 45.6% 26.8% 38.2% 45.4% 52.9% 25.8% 52.2% 46.0% 46.05%
FCF Margin 26.1% 29.5% 22.0% 29.3% 27.3% 22.4% 18.9% 13.7% 11.9% 18.8% 18.5% 19.3% 18.4% 15.7% 20.7% 23.2% 24.8% 28.8% 27.7% 32.7% 32.71%
OCF Margin 40.1% 44.6% 37.6% 42.9% 46.1% 44.8% 47.2% 45.6% 40.0% 43.5% 38.8% 36.1% 32.4% 17.6% 21.8% 26.5% 27.5% 40.0% 36.3% 38.1% 38.06%
ROE 3Y Avg snapshot only 14.34%
ROE 5Y Avg snapshot only 15.83%
ROA 3Y Avg snapshot only 12.51%
ROIC 3Y Avg snapshot only 30.14%
ROIC Economic snapshot only 13.52%
Cash ROA snapshot only 13.49%
Cash ROIC snapshot only 31.50%
CROIC snapshot only 27.07%
NOPAT Margin snapshot only 34.06%
Pretax Margin snapshot only 43.36%
R&D / Revenue snapshot only 9.20%
SGA / Revenue snapshot only 23.33%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 91.87 86.11 54.86 71.41 63.65 80.63 74.15 54.25 52.34 47.97 36.81 33.39 40.36 33.11 35.18 31.09 39.14 38.97 31.58 29.07 25.447
P/S Ratio 38.90 36.03 23.45 31.27 27.99 31.39 27.55 19.20 17.56 17.54 13.24 11.64 13.93 11.37 11.82 10.96 14.58 13.97 12.37 11.11 9.745
P/B Ratio 17.86 16.76 10.78 14.65 12.70 14.21 11.85 8.48 7.12 6.81 5.14 4.63 5.34 4.47 4.56 4.35 5.80 5.67 4.91 4.40 3.865
P/FCF 148.92 122.07 106.71 106.83 102.51 140.15 145.83 139.95 147.78 93.31 71.51 60.40 75.73 72.34 57.16 47.17 58.78 48.58 44.69 33.96 33.958
P/OCF 96.95 80.72 62.33 72.93 60.69 70.08 58.35 42.16 43.85 40.37 34.11 32.30 42.95 64.69 54.12 41.33 52.95 34.93 34.12 29.18 29.182
EV/EBITDA 80.34 77.28 48.11 63.21 56.29 67.11 62.27 44.69 42.99 41.22 30.08 26.04 32.70 25.33 26.97 23.90 30.95 29.84 24.41 21.33 21.335
EV/Revenue 37.70 34.78 22.20 30.03 26.80 30.14 26.28 17.83 16.24 16.09 11.87 10.24 12.60 9.97 10.45 9.58 13.31 12.71 11.17 9.79 9.792
EV/EBIT 84.14 81.18 50.55 66.32 59.12 70.67 65.87 47.53 45.99 44.46 32.61 28.61 36.25 28.21 30.32 26.67 33.41 32.53 25.79 22.73 22.728
EV/FCF 144.29 117.82 101.06 102.60 98.12 134.57 139.14 129.92 136.68 85.58 64.11 53.13 68.48 63.44 50.56 41.26 53.69 44.18 40.34 29.94 29.942
Earnings Yield 1.1% 1.2% 1.8% 1.4% 1.6% 1.2% 1.3% 1.8% 1.9% 2.1% 2.7% 3.0% 2.5% 3.0% 2.8% 3.2% 2.6% 2.6% 3.2% 3.4% 3.44%
FCF Yield 0.7% 0.8% 0.9% 0.9% 1.0% 0.7% 0.7% 0.7% 0.7% 1.1% 1.4% 1.7% 1.3% 1.4% 1.7% 2.1% 1.7% 2.1% 2.2% 2.9% 2.94%
PEG Ratio snapshot only 1.200
Price/Tangible Book snapshot only 4.655
EV/OCF snapshot only 25.730
EV/Gross Profit snapshot only 10.411
Acquirers Multiple snapshot only 24.661
Shareholder Yield snapshot only 0.43%
Graham Number snapshot only $9.71
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 14.32 12.42 22.83 15.82 14.74 14.38 15.59 7.28 9.31 8.87 9.85 6.63 10.09 9.05 19.06 9.34 14.78 12.18 26.14 9.14 9.142
Quick Ratio 13.74 11.92 22.01 15.24 14.26 13.90 15.05 7.04 8.98 8.53 9.48 6.38 9.77 8.73 18.38 9.03 14.33 11.80 25.34 8.87 8.875
Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.007
Net Debt/Equity -0.55 -0.58 -0.57 -0.58 -0.54 -0.57 -0.54 -0.61 -0.53 -0.56 -0.53 -0.56 -0.51 -0.55 -0.53 -0.55 -0.50 -0.51 -0.48 -0.52 -0.521
Debt/Assets 0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.02 0.01 0.02 0.03 0.03 0.02 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.006
Debt/EBITDA 0.02 0.02 0.02 0.01 0.04 0.04 0.11 0.13 0.11 0.17 0.22 0.20 0.13 0.06 0.02 0.04 0.04 0.03 0.03 0.04 0.036
Net Debt/EBITDA -2.57 -2.79 -2.69 -2.61 -2.51 -2.78 -2.99 -3.45 -3.49 -3.72 -3.47 -3.56 -3.46 -3.55 -3.52 -3.43 -2.93 -2.97 -2.63 -2.86 -2.862
Interest Coverage 1248.10 955.31 1087.06 1230.96 1195.81 860.56 556.43 349.95 276.47 234.60 235.93 251.34 243.28 307.44 335.02 413.87 549.10 523.45 583.79 594.26 594.260
Equity Multiplier 1.11 1.11 1.08 1.09 1.10 1.11 1.10 1.21 1.17 1.17 1.16 1.20 1.14 1.15 1.10 1.13 1.10 1.11 1.07 1.12 1.119
Cash Ratio snapshot only 7.352
Debt Service Coverage snapshot only 633.063
Cash to Debt snapshot only 79.456
FCF to Debt snapshot only 19.535
Defensive Interval snapshot only 1076.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.45 0.46 0.46 0.46 0.44 0.43 0.42 0.40 0.37 0.36 0.36 0.35 0.35 0.35 0.35 0.36 0.37 0.38 0.39 0.37 0.372
Inventory Turnover 0.72 0.67 0.72 0.71 0.80 0.83 0.89 0.88 0.83 0.75 0.74 0.74 0.81 0.77 0.79 0.79 0.93 0.90 0.91 1.19 1.190
Receivables Turnover 3.78 4.45 5.37 4.57 4.03 4.37 5.26 5.35 3.44 3.71 5.12 5.08 3.05 5.20 5.42 5.20 3.17 6.72 5.28 4.58 4.582
Payables Turnover 5.59 6.41 6.61 4.97 5.77 6.66 8.37 6.08 5.24 5.13 6.37 6.05 5.52 1.61 2.50 2.41 2.25 1.28 2.30 1.56 1.560
DSO 97 82 68 80 91 84 69 68 106 98 71 72 120 70 67 70 115 54 69 80 79.7 days
DIO 510 541 504 515 456 439 412 414 437 488 493 495 449 476 463 460 390 406 401 307 306.7 days
DPO 65 57 55 73 63 55 44 60 70 71 57 60 66 227 146 151 162 286 158 234 233.9 days
Cash Conversion Cycle 541 566 516 521 483 467 437 422 474 515 507 506 502 319 384 379 343 175 311 152 152.4 days
Fixed Asset Turnover snapshot only 1.384
Operating Cycle snapshot only 386.4 days
Cash Velocity snapshot only 0.752
Capital Intensity snapshot only 2.822
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 21.3% 27.0% 21.7% 17.2% 16.1% 10.9% 4.9% 5.2% -2.1% -5.3% -0.0% -0.3% 4.0% 9.1% 6.4% 10.0% 15.9% 14.8% 15.9% 11.4% 11.42%
Net Income 15.3% 21.4% 16.8% 16.6% 20.6% 3.2% -8.8% -14.9% -25.3% -11.1% -3.2% -1.7% 7.1% 2.5% -0.6% 11.2% 25.0% 19.9% 35.2% 20.8% 20.77%
EPS 15.3% 21.4% 16.8% 16.6% 20.6% 3.1% -8.8% -14.9% -25.3% -11.0% -3.2% -1.7% 7.1% 2.5% -0.6% 11.2% 25.0% 19.9% 35.2% 20.8% 20.77%
FCF 6.9% 28.1% -15.4% 35.7% 21.4% -15.8% -9.8% -50.7% -57.4% -20.5% -2.0% 40.1% 61.1% -8.8% 18.8% 32.6% 56.2% 1.1% 55.2% 56.9% 56.85%
EBITDA 20.2% 24.4% 18.6% 19.0% 17.8% 10.7% -4.1% -11.6% -22.3% -17.7% -6.6% -1.7% 6.1% 10.0% 4.5% 12.2% 29.4% 24.2% 36.8% 27.5% 27.51%
Op. Income 21.8% 22.2% 17.2% 17.6% 17.0% 0.8% -12.3% -19.3% -28.8% -12.9% -2.0% 2.5% 12.5% 7.0% 2.1% 11.3% 22.3% 16.2% 21.7% 9.0% 8.97%
OCF Growth snapshot only 59.94%
Asset Growth snapshot only 10.47%
Equity Growth snapshot only 11.61%
Debt Growth snapshot only 16.44%
Shares Change snapshot only 0.00%
Dividend Growth snapshot only -64.83%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 17.0% 17.3% 16.5% 15.1% 13.0% 11.9% 13.0% 12.7% 11.3% 10.1% 8.5% 7.2% 5.8% 4.6% 3.7% 4.9% 5.7% 5.8% 7.2% 6.9% 6.93%
Revenue 5Y 20.3% 20.9% 21.0% 19.8% 19.3% 18.4% 16.5% 15.3% 12.7% 11.1% 10.6% 9.9% 8.0% 7.7% 8.9% 9.4% 10.7% 10.8% 9.5% 8.6% 8.56%
EPS 3Y 12.6% 13.2% 13.3% 12.7% 10.4% 5.3% 6.2% 4.8% 1.3% 3.7% 1.0% -0.8% -1.2% -2.0% -4.3% -2.4% -0.0% 3.0% 9.1% 9.7% 9.68%
EPS 5Y 20.2% 21.2% 20.6% 18.9% 17.4% 13.4% 10.4% 8.4% 5.1% 5.9% 5.1% 3.7% 1.5% 1.3% 2.9% 4.7% 6.8% 6.5% 6.7% 5.5% 5.54%
Net Income 3Y 12.6% 13.2% 13.3% 12.7% 10.4% 5.3% 6.2% 4.8% 1.3% 3.7% 1.0% -0.8% -1.2% -2.0% -4.3% -2.4% -0.0% 3.0% 9.1% 9.7% 9.68%
Net Income 5Y 20.2% 21.2% 20.9% 19.3% 17.4% 13.4% 10.4% 8.4% 5.1% 5.9% 5.1% 3.7% 1.5% 1.3% 2.9% 4.7% 6.8% 6.5% 6.7% 5.5% 5.54%
EBITDA 3Y 12.6% 12.2% 12.8% 12.8% 10.6% 7.4% 8.0% 6.0% 3.2% 4.3% 2.0% 1.1% -1.0% 0.1% -2.2% -0.8% 2.2% 4.0% 10.1% 12.0% 12.04%
EBITDA 5Y 18.7% 19.0% 18.8% 17.5% 16.2% 14.0% 10.8% 8.6% 5.5% 5.2% 5.2% 4.5% 2.2% 2.3% 4.2% 5.6% 8.6% 9.1% 8.7% 8.1% 8.14%
Gross Profit 3Y 17.8% 17.9% 16.8% 15.2% 12.7% 11.5% 12.5% 12.4% 11.1% 10.0% 8.4% 6.9% 5.5% 4.4% 3.5% 4.7% 5.6% 5.8% 7.3% 6.6% 6.61%
Gross Profit 5Y 20.3% 20.8% 20.8% 19.5% 18.9% 18.1% 16.4% 15.3% 13.0% 11.3% 10.7% 9.8% 7.8% 7.4% 8.6% 9.3% 10.6% 10.7% 9.4% 8.1% 8.13%
Op. Income 3Y 13.5% 13.1% 13.2% 13.0% 10.5% 4.9% 5.3% 3.4% 0.5% 2.4% 0.3% -0.9% -2.1% -2.1% -4.3% -2.7% -0.7% 2.7% 6.8% 7.5% 7.53%
Op. Income 5Y 19.9% 21.0% 20.7% 19.2% 17.7% 12.9% 9.5% 7.2% 4.0% 4.9% 4.5% 3.6% 1.6% 1.5% 3.2% 4.8% 6.9% 5.9% 4.6% 3.4% 3.37%
FCF 3Y 13.3% 17.0% 13.0% 21.7% 24.9% 14.7% 4.4% -8.4% -17.9% -5.0% -9.3% -2.1% -5.9% -15.2% 1.6% -2.9% 2.3% 15.1% 21.8% 42.8% 42.83%
FCF 5Y 17.0% 22.4% 15.8% 20.8% 15.6% 10.0% 2.1% -2.9% -5.5% 1.4% 5.0% 4.5% 6.0% 1.8% 5.8% 7.4% 6.8% 10.4% 6.6% 14.3% 14.30%
OCF 3Y 21.0% 20.4% 17.0% 17.1% 20.9% 19.9% 18.2% 17.5% 9.3% 12.9% 5.8% 5.1% -1.5% -23.3% -13.5% -10.6% -11.0% 1.9% -1.8% 0.7% 0.71%
OCF 5Y 19.3% 24.0% 19.9% 21.6% 22.3% 20.3% 18.5% 19.3% 15.0% 12.3% 11.6% 7.2% 4.8% -6.9% -4.1% 0.7% 1.6% 10.6% 6.4% 8.5% 8.50%
Assets 3Y 22.8% 22.2% 16.5% 16.9% 16.0% 15.5% 15.9% 19.6% 17.1% 16.9% 15.8% 17.0% 13.4% 11.9% 10.7% 12.1% 10.5% 9.6% 9.2% 8.1% 8.09%
Assets 5Y 22.8% 22.6% 22.0% 22.1% 21.6% 21.0% 20.1% 22.3% 20.2% 19.4% 16.0% 16.7% 14.5% 13.7% 13.0% 14.4% 13.1% 12.5% 11.7% 13.0% 13.00%
Equity 3Y 21.6% 21.4% 18.0% 18.0% 17.1% 15.9% 16.0% 16.4% 15.1% 14.5% 14.1% 13.9% 12.3% 10.7% 9.9% 10.8% 10.4% 9.8% 10.1% 10.8% 10.83%
Book Value 3Y 21.6% 21.4% 18.0% 18.0% 17.1% 15.9% 16.0% 16.4% 15.1% 14.5% 14.1% 13.8% 12.3% 10.7% 9.9% 10.8% 10.4% 9.8% 10.1% 10.8% 10.83%
Dividend 3Y -3.8% -3.8% -3.8% 7.9% 7.9% 7.9% 7.9% -87.7% -0.1% 0.1% 0.2% 7.2% -2.2% -2.6% 12.1% 12.1% -18.9% -18.6% -29.4% -29.4% -29.41%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.98 0.96 0.99 0.99 0.97 0.96 0.99 0.99 0.94 0.88 0.92 0.92 0.89 0.85 0.87 0.90 0.89 0.88 0.93 0.95 0.952
Earnings Stability 0.94 0.93 0.98 0.98 0.94 0.90 0.87 0.75 0.44 0.57 0.57 0.35 0.08 0.18 0.15 0.20 0.21 0.39 0.28 0.28 0.278
Margin Stability 0.99 0.99 0.99 0.99 0.99 0.99 1.00 0.99 0.99 0.99 1.00 1.00 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.993
Rev. Growth Consistency 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 1.00 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.91 0.93 0.93 0.92 0.99 0.96 0.94 0.90 0.96 0.99 0.99 0.97 0.99 1.00 0.96 0.90 0.92 0.86 0.92 0.917
Earnings Smoothness 0.86 0.81 0.84 0.85 0.81 0.97 0.91 0.84 0.71 0.88 0.97 0.98 0.93 0.98 0.99 0.89 0.78 0.82 0.70 0.81 0.812
ROE Trend -0.02 -0.02 -0.01 -0.01 0.00 -0.02 -0.04 -0.05 -0.06 -0.04 -0.04 -0.04 -0.04 -0.02 -0.02 -0.01 0.01 0.01 0.02 0.01 0.012
Gross Margin Trend -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 -0.01 -0.012
FCF Margin Trend 0.01 0.04 -0.06 0.04 -0.01 -0.07 -0.08 -0.14 -0.15 -0.07 -0.02 -0.02 -0.01 -0.05 0.02 0.07 0.10 0.12 0.08 0.11 0.114
Sustainable Growth Rate 15.6% 15.9% 16.4% 16.0% 15.7% 13.1% 11.5% 16.5% 9.1% 9.8% 9.8% 9.6% 9.5% 9.7% 7.0% 8.3% 13.5% 13.2% 14.5% 14.0% 13.97%
Internal Growth Rate 16.4% 16.8% 17.7% 17.1% 16.6% 13.4% 11.7% 16.7% 8.7% 9.4% 9.5% 8.7% 9.0% 9.1% 6.7% 7.7% 13.7% 13.3% 15.3% 14.2% 14.19%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.95 1.07 0.88 0.98 1.05 1.15 1.27 1.29 1.19 1.19 1.08 1.03 0.94 0.51 0.65 0.75 0.74 1.12 0.93 1.00 0.996
FCF/OCF 0.65 0.66 0.58 0.68 0.59 0.50 0.40 0.30 0.30 0.43 0.48 0.53 0.57 0.89 0.95 0.88 0.90 0.72 0.76 0.86 0.859
FCF/Net Income snapshot only 0.856
OCF/EBITDA snapshot only 0.829
CapEx/Revenue 14.0% 15.1% 15.6% 13.6% 18.8% 22.4% 28.3% 31.8% 28.2% 24.7% 20.3% 16.8% 13.9% 12.7% 11.9% 13.6% 12.5% 11.2% 8.6% 5.4% 5.35%
CapEx/Depreciation snapshot only 1.903
Accruals Ratio 0.01 -0.01 0.02 0.00 -0.01 -0.03 -0.04 -0.04 -0.02 -0.02 -0.01 -0.00 0.01 0.06 0.04 0.03 0.04 -0.02 0.01 0.00 0.001
Sloan Accruals snapshot only 0.026
Cash Flow Adequacy snapshot only 3.745
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.3% 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.0% 0.7% 0.7% 0.9% 1.0% 0.8% 0.9% 1.3% 1.4% 0.3% 0.4% 0.4% 0.4% 1.23%
Dividend/Share $0.16 $0.16 $0.16 $0.20 $0.20 $0.20 $0.20 $0.00 $0.20 $0.20 $0.20 $0.20 $0.19 $0.19 $0.29 $0.29 $0.10 $0.10 $0.10 $0.10 $0.25
Payout Ratio 25.9% 24.8% 23.3% 28.3% 26.9% 30.2% 32.1% 0.1% 36.0% 34.1% 33.5% 34.1% 31.4% 30.7% 47.4% 43.2% 13.4% 13.8% 12.3% 12.6% 12.59%
FCF Payout Ratio 41.9% 35.1% 45.4% 42.4% 43.4% 52.4% 63.2% 0.2% 1.0% 66.2% 65.0% 61.7% 59.0% 67.0% 77.1% 65.6% 20.2% 17.2% 17.5% 14.7% 14.71%
Total Payout Ratio 25.9% 24.8% 23.3% 28.3% 26.9% 30.2% 32.1% 0.1% 65.4% 61.7% 60.5% 61.7% 31.4% 30.7% 47.4% 43.2% 13.4% 13.8% 12.3% 12.6% 12.59%
Div. Increase Streak 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0
Chowder Number -0.11 -0.11 -0.11 0.26 0.26 0.26 0.26 -1.00 0.00 0.01 0.02 543.78 -0.06 -0.07 0.42 0.42 -0.46 -0.46 -0.64 -0.64 -0.644
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 0.6% 0.7% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.2% -0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.3% 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.0% 0.6% 0.6% 0.7% 0.8% 0.8% 0.9% 1.3% 1.4% 0.3% 0.4% 0.4% 0.4% 0.43%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.86 0.86 0.86 0.86 0.87 0.87 0.89 0.90 0.91 0.90 0.88 0.87 0.87 0.87 0.87 0.88 0.88 0.88 0.89 0.88 0.881
Interest Burden (EBT/EBIT) 1.10 1.14 1.13 1.12 1.12 1.04 1.04 1.05 1.05 1.13 1.12 1.12 1.14 1.12 1.12 1.12 1.07 1.04 1.02 1.01 1.006
EBIT Margin 0.45 0.43 0.44 0.45 0.45 0.43 0.40 0.38 0.35 0.36 0.36 0.36 0.35 0.35 0.34 0.36 0.40 0.39 0.43 0.43 0.431
Asset Turnover 0.45 0.46 0.46 0.46 0.44 0.43 0.42 0.40 0.37 0.36 0.36 0.35 0.35 0.35 0.35 0.36 0.37 0.38 0.39 0.37 0.372
Equity Multiplier 1.11 1.11 1.09 1.10 1.10 1.11 1.09 1.15 1.14 1.14 1.13 1.20 1.16 1.16 1.13 1.16 1.12 1.13 1.09 1.12 1.125
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.62 $0.65 $0.69 $0.71 $0.75 $0.67 $0.63 $0.60 $0.56 $0.59 $0.61 $0.59 $0.60 $0.61 $0.60 $0.66 $0.75 $0.73 $0.81 $0.80 $0.80
Book Value/Share $3.18 $3.32 $3.49 $3.46 $3.74 $3.78 $3.92 $3.86 $4.10 $4.17 $4.33 $4.28 $4.51 $4.50 $4.64 $4.71 $5.03 $5.00 $5.23 $5.26 $5.43
Tangible Book/Share $2.85 $2.98 $3.11 $3.08 $3.30 $3.51 $3.55 $3.51 $3.74 $3.81 $3.98 $3.93 $4.16 $4.15 $4.29 $4.38 $4.70 $4.68 $4.95 $4.98 $4.98
Revenue/Share $1.46 $1.54 $1.61 $1.62 $1.70 $1.71 $1.68 $1.71 $1.66 $1.62 $1.68 $1.70 $1.73 $1.77 $1.79 $1.87 $2.00 $2.03 $2.08 $2.09 $2.09
FCF/Share $0.38 $0.46 $0.35 $0.47 $0.46 $0.38 $0.32 $0.23 $0.20 $0.30 $0.31 $0.33 $0.32 $0.28 $0.37 $0.44 $0.50 $0.58 $0.57 $0.68 $0.68
OCF/Share $0.59 $0.69 $0.60 $0.70 $0.78 $0.77 $0.79 $0.78 $0.66 $0.70 $0.65 $0.61 $0.56 $0.31 $0.39 $0.50 $0.55 $0.81 $0.75 $0.79 $0.79
Cash/Share $1.78 $1.95 $2.01 $2.02 $2.07 $2.17 $2.20 $2.43 $2.26 $2.46 $2.45 $2.52 $2.39 $2.51 $2.46 $2.60 $2.56 $2.59 $2.53 $2.78 $2.78
EBITDA/Share $0.69 $0.69 $0.74 $0.77 $0.81 $0.77 $0.71 $0.68 $0.63 $0.63 $0.66 $0.67 $0.67 $0.70 $0.69 $0.75 $0.86 $0.86 $0.95 $0.96 $0.96
Debt/Share $0.01 $0.01 $0.01 $0.01 $0.04 $0.03 $0.08 $0.09 $0.07 $0.11 $0.14 $0.13 $0.09 $0.04 $0.01 $0.03 $0.04 $0.03 $0.03 $0.03 $0.03
Net Debt/Share $-1.77 $-1.94 $-1.99 $-2.01 $-2.03 $-2.14 $-2.13 $-2.35 $-2.19 $-2.36 $-2.31 $-2.39 $-2.30 $-2.47 $-2.44 $-2.57 $-2.53 $-2.57 $-2.50 $-2.74 $-2.74
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 32.990
Altman Z-Prime snapshot only 60.067
Piotroski F-Score 5 6 7 6 6 5 4 4 5 5 5 4 6 7 6 8 8 7 6 5 5
Beneish M-Score -2.16 -2.25 -2.00 -2.33 -2.41 -2.59 -2.71 -2.70 -2.68 -2.81 -2.51 -2.47 -2.40 -1.99 -2.30 -2.35 -2.22 -2.23 -2.01 -1.93 -1.932
Ohlson O-Score snapshot only -14.062
ROIC (Greenblatt) snapshot only 19.62%
Net-Net WC snapshot only $3.00
EVA snapshot only $240078303.59
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 93.78 94.58 94.72 94.24 94.94 94.44 94.44 93.74 94.34 93.76 94.65 94.31 95.01 94.96 95.68 95.53 95.48 95.48 94.14 95.00 95.003
Credit Grade snapshot only 1
Credit Trend snapshot only -0.524
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 86
Sector Credit Rank snapshot only 93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms